Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer

PURPOSE: The clinical utility of plasma methylated septin 9 (mSEPT9) DNA in screening and recurrence monitoring for colorectal cancer (CRC) is highly promising. The present study was performed to determine the diagnostic value of mSEPT9 in CRC detection and recurrence monitoring in Chinese patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Pingxia, Zhu, Xianjin, Song, Yanfang, Luo, Yue, Lin, Junsheng, Zhang, Junrong, Cao, Yingping, Huang, Zhengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271001/
https://www.ncbi.nlm.nih.gov/pubmed/35818587
http://dx.doi.org/10.1155/2022/7087885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271001/
https://www.ncbi.nlm.nih.gov/pubmed/35818587
http://dx.doi.org/10.1155/2022/7087885

Ejemplares similares